Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Rectal Neoplasms × Exercise × 1 year × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Motor Activity 47 Breast Neoplasms 27 Neoplasms 17 Colorectal Neoplasms 7 Prostatic Neoplasms 6 Obesity 6 Lymphedema 5 Colonic Neoplasms 5 Precursor Cell Lymphoblastic Leukemia-Lymphoma 4 Ovarian Neoplasms 4 Multiple Myeloma 4 Lymphoma, Follicular 4 Hematologic Neoplasms 4 Fatigue 4 Endometrial Neoplasms 4 Brain Neoplasms 4 Sarcopenia 3 Polycystic Ovary Syndrome 3 Pancreatic Neoplasms 3 Lymphoma 3 Esophageal Neoplasms 3 Carcinoma, Non-Small-Cell Lung 3 Skin Neoplasms 2 Recurrence 2 Peripheral Nervous System Diseases 2 Overweight 2 Neoplasm Metastasis 2 Melanoma 2 Medulloblastoma 2 Malnutrition 2

Interventions

Oxaliplatin 37 Capecitabine 34 Fluorouracil 27 Leucovorin 22 Radiotherapy 19 Bevacizumab 13 Cetuximab 12 Irinotecan 10 Nivolumab 9 Drug Therapy 9 Radiotherapy, Intensity-Modulated 8 Magnetic Resonance Spectroscopy 8 pembrolizumab 7 Specimen Handling 7 Folfox protocol 7 trifluridine tipiracil drug combination 6 Surgical Procedures, Operative 6 Chemoradiotherapy 6 dehydroftorafur 5 Radiation 5 spartalizumab 4 dostarlimab 4 atezolizumab 4 XELOX 4 Sigmoidoscopy 4 Endoscopy 4 Endoscopic Mucosal Resection 4 Chemotherapy, Adjuvant 4 Biopsy 4 tislelizumab 3

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT05789433 2025-07-03

RESTORE

AdventHealth Translational Research Institute

Phase NA Recruiting

Gastrointestinal

Colonic Neoplasms, Rectal Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡